As prostate cancer progresses, the combination of PTEN and TP53 gene deletions and rearrangements of the ERG gene serves as a crucial driving factor (35–37) Among these alterations, the incidence of ERG rearrangement is the highest (38). The gene discussed is ERG; the disease is prostate carcinoma.